Skip to main content
ABSTRACT & COMMENTARY

Pancreatic Cancer Patients Live Longer when nab-Paclitaxel Is Added to Gemcitabine

It is indeed ironic that 16 years after the landmark Burris study, innovations in pancreatic cancer treatment still lack essential quality-of-life data.